Influence of Adiponutrin in Chronic Liver Disease
Study of Metabolism Influence in Human Alcoholic Liver Disease
Sponsor: Erasme University Hospital
Listed as NCT01122797, this observational or N/A phase trial focuses on Alcoholic Liver Disease and remains completed. Sponsored by Erasme University Hospital, it has been updated 9 times since 2003, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
▶ Show 4 earlier versions
-
May 2018 — Nov 2020 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Completed NA
-
Jan 2017 — Aug 2017 [monthly]
Completed NA
First recorded
Jan 2003
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Erasme University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .